새로운 항정신병약물의 부작용과 처치에 관한 분석

참고문헌

1) Casey DE(1995) : Neuroleptic-induced acute extrapyramidal syndromes and tardive dyskinesia. In: Schizophrenia. Ed by Hirsch S and Weinberger DR, Oxford, England, Blackwell, pp 546-565
2) Peacock L, Solgaard T, Lublin H, Gerlach J(1996): Clozapine versus typical antipsychotics: a retro- and prospective study of extrapyramidal side effects. Psychopharmacology(Berl) 124: 188-196
3) Safferman A.Z, Lieberman JA, Pollack S, Kane JM(1992): Clozapine and akathisia. Biol Psychiatry 31: 753-754
4) Chengappa KN, Shelton MD, Baker RW, Schooler NR, Baird J, Delaney J(1994) : The prevalence of akathisia in patients receiving stable doses of clozapine. J clin Psychiatry 55(4): 142-145
5) Safferman A.Z, Lieberman JA, Pollack S, Kane JM(1993): Akathisia and clozapine treatment. Schizophrenia Res 9: 248-249
6) Kastrup O, Gastpar M, Schwartz M(1994) : Acute dystonia due to clozapine(letter). J Neurology, Neurosurgery and Psychiatry 55:119
7) Chouinard G, Jones B, Remington G, Bloom D, Addington D, MacEwan GW, Labelle A, Beauclair L, Arnott W(1993): Canadian multicenter placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients. J clin Psychopharmacol 73: 25-40
8) Marder SR, Meibach RC(1994) : Risperidone in the treatment of schizophrenia. Am J Psychiatry, 151:825-835
9) Simpson GM, Lindenmayer J-P(1997): Extrapyramidal symptoms in patients treated with risperidone. J Clin Psychopharmacol 17: 194-201
10) Kopala LC, Kimberley PG, Honer WG(1994): Extrapyramidal signs and clinical symptoms in first-episode schizophrenia: response to low-dose risperidone. J Clin Psychopharmacol 17: 308-313
11) Beasley CM, Tollefson G, Tran P, Satterlee W, Sanger T, Hamilton S, the olanzapine HGAD study group(1996): Olanzapine versus placebo and haloperidol: acute phase results of the North Americal double-blind olanzapine trial. Neuropsychopharmacology 14: 111-123
12) Tran PV, Dellva MA, Tollefson GD, Beasley CM, Potvin JH, Kiesler GM(1997): Extrapyramidal symptoms and tolerability of olanzapine versus haloperidol in the acute treatment of schizophrenia. J Clin Psychiatry 58: 205-211
13) Leysen JE, Janssen PMF, Schotte A, Luyten WH, Megens AA(1993): Interaction of antipsychotic drugs with neurotransmitter receptor sites in vitro and in vivo in relation to pharmacological and clinical effects: role of 5HT2 receptors. Psychopharmacology(Berl) 112: S40-S54
14) Kapur S, Remington G(1996): Serotonin-dopamine interaction and its relevance to schizophrenia. Am J Psychiatry 153: 466-476
15) Skarsfeldt T(1995) : Differential effects of repeated administration of novel antipsychotic drug on the activity of midbrain dopamine neurons in the rat. Eur J Pharmacol 281: 289-294
16) Stockton ME, Rasmussen K(1996): Electrophysiological effects of olanzapine, a novel atypical antipsychotic, on A19 and A10 dopamine neurons. Neuropsychopharmacology 14: 97-104
17) Lieberman JA, Saltz BL, Johns CA, Pollack S, Borenstein M, Kane JM(1991): The effects of clozapine on tardive dyskinesia. Br J Psychiatry 158: 503-510
18) Spivak B, Mester R, Abesgaus L, Wittenberg N, Aldersberg S, Gonen N, Weizman A(1997): Clozapine treatment for neuroleptic-induced tardive dyskinesia, parkinsonism, and chronic akathisia in schizophrenic patients. J Clin Psychiatry 58: 318-322
19) Tamminga CA, Thaker GK, Moran M, Kakigi T, Gao XM(1994): Clozapine in tardive dyskinesia: Observation from human and animal model studies. J Clin Psychiatry 55(Suppl B): 102-106
20) Addington DE, Toews J, Addington JM(1995) : Risperidone and tardive dyskinesia: Case report. J Clin Psychiatry 56: 484-485
21) Arnand VS, Dewan MJ(1996): Withdrawal-emergent dyskinesia in a patient on risperidone undergoing dosage reduction. Ann Clin Psychiatry 8: 179-181
22) Buzan RD(1996): Risperidone-induced tardive dyskinesia(letter). Am J Psychiatry 153: 734-735
23)Woerner MG, Sheitman BB, Lieberman JA, Kane J(1996): Tardive dyskinesia induced by risperidone?(letter) Am J Psychiatry 1996: 843
24) Daniel DG, Smith K, Hyde T, Egan M(1996): Neuroleptic-induced tardive dyskinesia (letter). Am J Psychiatry 153: 734
25) Saran BM(1998): risperidone-induced tardive dyskinesia(letter). J Clin Psychiatry 59: 29-30
26) Gutierrez-Esteinou R, Grebb JA(1997): Risperidone: an analysis of the first three years in general use. Int Clin Psychopharmacol 12(suppl 4): S3-S10
27) Tollefson GD, Beasley CM, Tamura RN, Tran PV, Potvin JH(1997): Blind, controlled, lon-term study of the comparative incidence of treatment-emergent tardive dyskinesia with olanzapine or haloperidol. Am J Psychiatry 154: 1248-1254
28) Keck PE Jr, Pope HG Jr, McElroy SL(1987): Frequency and presentaion of neuroleptic malignant syndrome: a prospective study. Am J Psychiatry 144: 1344-1346
29)Umbricht D, Kane JM(1996): Medical Complications of New Antipsychotic Drugs. Schizophr Bull 22: 475-481
30) Hasan S, Buckley P(1998): Novel antipsychotics and the neuroleptic malignant syndrome: a review and critique. Am J Psychiatry 155: 1113-1116
31) Pelonero AL, Levenson JL, Pandurangi AK(1998): Neuroleptic malignant syndrome: a review. Psychiatric Services 49: 1163-1172
32) Breier A, Buchanan RW, Kirkpatrick B, Davis OR, Irish D, Summerfelt A, Carpenter WT(1994): Effects of clozapine on positive and negative symptoms in outpatients with schizophrenia. Am J Psychiatry 151: 20-26
33) Lieberman JA, Safferman AZ, Pollack S(1994): Clinical effects of clozapine in chronic schizophrenia: response to treatment and predictors of outcome. Am J Psychiatry 151: 1744-1752
34) Young CR, Bowers MB, Mazure CM(1998): Management of the adverse effects of clozapine. Schizophr Bull 24: 381-390
35) Peuskens J(1995): Risperidone in the treatment of patients with chronic schizophrenia : A multi-national, multi-centre, double-blind, parallel-group study versus haloperidol. Br J Psychiatry 166: 712-733
36) Hoyberg OJ, Fensbo C, Remvig J, Lingjaerde O, Sloth-Nielson M, Salvensen I(1993) : Risperidone versus perphenazine in the treatment of chronic schizophrenic patients with acute exacerbation. Acta Psychiatr Scand 88: 395-402
37) van Kammen D, McEvoy J, Targum S, Kardatzki D, Sebree TB(1996): A randomized, controlled, dose-ranging trial of sertindol in patients with schizophrenia. Psychopharmacology(Berl) 124: 168-175
38) Brecher MB, Lemmens P, van Baelen B(1997): Tolerability and cardiovascular safety of risperidone. In: New Research Program and Abstracts of the 150th Annual Meeting of the American Psychiatric Association; May 21, San Diego, Calif. Abstract NR 612: 233
39) Tran PV, Hamilton SH, Kuntz AJ, Potvin JH, Andersen SW, Beasley C, Tollefson GD(1997) : Double-blind comparison of olanzapine versus risperidone in the treatment of schizophrenia and other psychotic disorders. J Clin Psychopharmacol 17: 407-418
40) Safferman AZ, Lieberman JA, Kane JM, Szymanski S, Kinon B(1991): Update on the clinical efficacy and side effects of clozapine. Schizophr Bull 17: 247-261
41) Marinkovic D, Timtijevic I, Babinski T, Totic S(1994): The side effects of clozapine: a four year follow-up study. Prog Neuropsychopharmacology 18: 537-544
42) Stahl SM(1998): Neuropharmacology of obesity: my receptors made me eat it. J Clin Psychiatry 59: 447-448
43) Umbricht D, Pollack S, Kane JM(1994): Clozapine and weight gain. J Clin Psychiatry 55(suppl B): 157-160
44) Bustillo JR, Buchanan RW, Donna Irish, Breier A(1996): Differential effect of clozapine on weight: a controlled study. Am J Psychiatry 153: 817-819
45) Baker RW, Chengappa KN, Baird JW, Steingard MD, Christ MA, Schooler NR(1992): Emergence of dbsessive-compulsive symptoms during treatment with clozapine. J Clin Psychiatry 53: 439-442
46) Patil VJ(1992): Development of transient obsessive-compulsive symptoms during treament with clozapine(letter). Am J Psychiatry 149: 272
47) Levkovitch Y, Kronnenberg Y, Gaoni B(1995): Can clozapine trigger OCD?(letter) J Am Child Adolescent Psychiatry 34: 263
48) Ghaemi SN, Zarate CA, Popli AP, Pilay SS, Cole JO(1995): Is there a relationship between clozapine and obsessive-compulsive disorder?: a retrospective chart review. Compr Psychiatry 36: 267-270
49) Kopala LC, Honer WG(1994): Risperidone, serotonergic mechanism, and obsessive- compulsive symptoms in schizophrenia(letter). Am J Psychiatry 151: 1714-1715
50) Remington G, Adams M(1994): Risperidone and obsessive-compulsive symptoms (letter). J Clin Psychopharmacol 14: 357-358